335 related articles for article (PubMed ID: 34599546)
41. Co-delivery of doxorubicin and DNAzyme using ZnO@polydopamine core-shell nanocomposites for chemo/gene/photothermal therapy.
Liu M; Peng Y; Nie Y; Liu P; Hu S; Ding J; Zhou W
Acta Biomater; 2020 Jul; 110():242-253. PubMed ID: 32438113
[TBL] [Abstract][Full Text] [Related]
42. PSMA-targeted melanin-like nanoparticles as a multifunctional nanoplatform for prostate cancer theranostics.
Dai L; Shen G; Wang Y; Yang P; Wang H; Liu Z
J Mater Chem B; 2021 Jan; 9(4):1151-1161. PubMed ID: 33434248
[TBL] [Abstract][Full Text] [Related]
43. Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity.
Dong Z; Wang Y; Guo J; Tian C; Pan W; Wang H; Yan J
Drug Des Devel Ther; 2022; 16():2683-2693. PubMed ID: 35983428
[TBL] [Abstract][Full Text] [Related]
44. Near-Infrared Light-Activated Mesoporous Polydopamine for Temporomandibular Joint Osteoarthritis Combined Photothermal-Chemo Therapy.
Li Q; Hou Y; Cao P; Bi R; Zhu S
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240401
[TBL] [Abstract][Full Text] [Related]
45. Study on combination therapy for lung cancer through pemetrexed-loaded mesoporous polydopamine nanoparticles.
Xu J; Xu W; Wang Z; Jiang Y
J Biomed Mater Res A; 2023 Feb; 111(2):158-169. PubMed ID: 36479812
[TBL] [Abstract][Full Text] [Related]
46. Metal-polyphenol polymer modified polydopamine for chemo-photothermal therapy.
Xu L; Luo Z; Liu Q; Wang C; Zhou F; Zhou M
Front Chem; 2023; 11():1124448. PubMed ID: 36762199
[TBL] [Abstract][Full Text] [Related]
47. CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy.
Wang Z; Wang L; Prabhakar N; Xing Y; Rosenholm JM; Zhang J; Cai K
Acta Biomater; 2019 Mar; 86():416-428. PubMed ID: 30611792
[TBL] [Abstract][Full Text] [Related]
48. Polydopamine doped reduced graphene oxide/mesoporous silica nanosheets for chemo-photothermal and enhanced photothermal therapy.
Liu R; Zhang H; Zhang F; Wang X; Liu X; Zhang Y
Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():138-145. PubMed ID: 30606519
[TBL] [Abstract][Full Text] [Related]
49. The tumor-targeting core-shell structured DTX-loaded PLGA@Au nanoparticles for chemo-photothermal therapy and X-ray imaging.
Hao Y; Zhang B; Zheng C; Ji R; Ren X; Guo F; Sun S; Shi J; Zhang H; Zhang Z; Wang L; Zhang Y
J Control Release; 2015 Dec; 220(Pt A):545-555. PubMed ID: 26590021
[TBL] [Abstract][Full Text] [Related]
50. Oxygen-supplementing mesoporous polydopamine nanosponges with WS
Wang Y; Song S; Lu T; Cheng Y; Song Y; Wang S; Tan F; Li J; Li N
Biomaterials; 2019 Nov; 220():119405. PubMed ID: 31408811
[TBL] [Abstract][Full Text] [Related]
51. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
52. Graphene oxide-wrapped PEGylated liquid crystalline nanoparticles for effective chemo-photothermal therapy of metastatic prostate cancer cells.
Thapa RK; Youn YS; Jeong JH; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2016 Jul; 143():271-277. PubMed ID: 27022866
[TBL] [Abstract][Full Text] [Related]
53. A multifunctional nanoplatform based on MoS
Yang Y; Wu J; Bremner DH; Niu S; Li Y; Zhang X; Xie X; Zhu LM
Colloids Surf B Biointerfaces; 2020 Jan; 185():110585. PubMed ID: 31683203
[TBL] [Abstract][Full Text] [Related]
54. Mesoporous Doxorubicin-Loaded Polydopamine Nanoparticles Coated with a Platelet Membrane Suppress Tumor Growth in a Murine Model of Human Breast Cancer.
Ren D; Williams GR; Zhang Y; Ren R; Lou J; Zhu LM
ACS Appl Bio Mater; 2022 Jan; 5(1):123-133. PubMed ID: 35014822
[TBL] [Abstract][Full Text] [Related]
55. Specific aptamer-conjugated mesoporous silica-carbon nanoparticles for HER2-targeted chemo-photothermal combined therapy.
Wang K; Yao H; Meng Y; Wang Y; Yan X; Huang R
Acta Biomater; 2015 Apr; 16():196-205. PubMed ID: 25596325
[TBL] [Abstract][Full Text] [Related]
56. Synergistic action of lactoferrin in enhancing the safety and effectiveness of docetaxel treatment against prostate cancer.
Muj C; Mukhopadhyay S; Jana P; Kondapi AK
Cancer Chemother Pharmacol; 2023 May; 91(5):375-387. PubMed ID: 36977771
[TBL] [Abstract][Full Text] [Related]
57. A Magnetic T7 Peptide&AS1411 Aptamer-Modified Microemulsion for Triple Glioma-Targeted Delivery of Shikonin and Docetaxel.
Wang H; Chen W; Wu G; Kong J; Yuan S; Chen L
J Pharm Sci; 2021 Aug; 110(8):2946-2954. PubMed ID: 33785350
[TBL] [Abstract][Full Text] [Related]
58. Development of novel PLGA nanoparticles with co-encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells.
Sokol MB; Nikolskaya ED; Yabbarov NG; Zenin VA; Faustova MR; Belov AV; Zhunina OA; Mollaev MD; Zabolotsky AI; Tereshchenko OG; Severin ES
J Biomed Mater Res B Appl Biomater; 2019 May; 107(4):1150-1158. PubMed ID: 30281905
[TBL] [Abstract][Full Text] [Related]
59. Dynamically PEGylated and Borate-Coordination-Polymer-Coated Polydopamine Nanoparticles for Synergetic Tumor-Targeted, Chemo-Photothermal Combination Therapy.
Liu S; Pan J; Liu J; Ma Y; Qiu F; Mei L; Zeng X; Pan G
Small; 2018 Mar; 14(13):e1703968. PubMed ID: 29430825
[TBL] [Abstract][Full Text] [Related]
60. In vitro Antitumor Properties of Fucoidan-Coated, Doxorubicin-Loaded, Mesoporous Polydopamine Nanoparticles.
Xu H; Ling J; Zhao H; Xu X; Ouyang XK; Song X
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
